ExaWizards Inc.
[ExaWizards] Notice of Business Restructuring and Subsidiary Integration | May 2026
ExaWizards is consolidating its caregiving business into its subsidiary ExaMD through a merger and split, scheduled for completion in July 2026, aiming to improve operational efficiency and optimize management resources.
Key Figures
- Net assets (ExaMD): 234 million yen
- Net assets (ExaWizards): 4,750 million yen
- Sales (ExaWizards): 11,996 million yen
AI要約
Overview of the Business Restructuring
ExaWizards has decided to reorganize its AI product business portfolio in the social domain, specifically its caregiving segment, by consolidating operations into the wholly owned subsidiary ExaMD. This aims to accelerate AI adoption in the medical and caregiving sectors, streamline operations, and optimize management resources. Specifically, an absorption-type merger between subsidiaries and an absorption-type split between parent and subsidiary companies will be carried out, with effective date scheduled for July 1, 2026.
Future Outlook and Impact
This restructuring is expected to enhance the efficiency of ExaWizards' business operations and promote AI adoption in the medical and caregiving fields. The impact on the full-year consolidated results for the fiscal year ending March 2027 is projected to be minimal. The integration of businesses and quicker decision-making aim to increase long-term corporate value. Post-completion, there will be no change to the company name or head office location, ensuring business continuity.
ExaWizards Inc.
Company overview · Stock price · Financial data · All IR
